Effect of lovastatin on behavior in children and adults with fragile X syndrome: An open‐label studyArtuela Çaku, François Corbin, David Pellerin et al.|American Journal of Medical Genetics Part A|2014Cited by 78
Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet’s signaling cascades as new outcome measures in clinical trialsDavid Pellerin, François Corbin, Artuela Çaku et al.|Biomarkers|2016Cited by 50